CorVent Medical announced that it received CE mark approval for its Respond-19 ventilator and is preparing to launch it in Europe. Santa Clara, Calif.-based CorVent’s Respond-19 ventilator allows hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS). The system received FDA emergency use authorization (EUA) for primary critical care use in December […]
CorVent Medical
CorVent Medical wins EUA for multiple patient ventilator
CorVent Medical announced today that it received FDA emergency use authorization (EUA) for primary critical care use of its Respond-19 ventilator. Respond-19 is designed for the rapid expansion of critical care ventilation capacity by allowing hospitals to treat more patients suffering from acute respiratory distress syndrome (ARDS) amid the COVID-19 pandemic, according to a news […]
Startup CorVent Medical raises $4.5m for single-use ventilator
CorVent Medical today announced the closing of a $4.5 million seed financing round to support the commercialization of a single-use, critical care ventilator. The financing round is led by European life sciences venture capital firm Sofinnova Partners with participation from Redmile Group, Exor Seeds, Genesis Medtech Group, The Deerfield Foundation, The Pagliuca Family Office and […]
